Next generation antineoplastic agents

A review on structurally modified vinblastine (VBL) analogues

Ashanul Haque, Md Ataur Rahman, Md Serajul Haque Faizi, Muhammad Khan

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Background: Throughout the history of human civilizations, cancer has been a major health problem. Despite the advancements made by modern medical sciences, complete treatment or removal of cancerous cells is still a challenging task. Vinblastine, an alkaloid obtained from Catharanthus roseus (L.) G. Don is one of the prominent antineoplastic agents that is being clinically used. To improve the biological potential and reduce sideeffects of this structurally complex molecule, several related analogues have been reported. The present article reviews recently reported structurally modified vinblastine analogues and its impact on biological activity. Methods: We carried out a comprehensive database search on recently reported vinblastine analogues. Both upper (catharanthine) and lower (vindoline) structural units have been considered. The role of functional group modification on anticancer activities has been discussed. In addition, formulations based on vinblastine being considered by NIH, USA for different types of cancers have also been discussed._ Results: Around fifty papers were included in the review, including computational and experimental ones. These papers were analysed to discuss the mechanism of action of the parent vinblastine molecule and their analogues. The importance of each functionalities on its anticancer activity have been discussed. This reviewed identified the potential sites of vinblastine core where modification led to improved anticancer activity. Furthermore, several new formulations have also been discussed which are under different phases of clinical trial. Conclusion: The present article highlights the importance of vinblastine in cancer chemotherapy. Literature survey confirms that it is now possible to synthesize new molecules with activity in picomolar range. Not only the periphery of the molecule, the core structure of this magical molecule can be modified to achieve next generation antineoplastic agents.

Original languageEnglish
Pages (from-to)1650-1662
Number of pages13
JournalCurrent Medicinal Chemistry
Volume25
Issue number14
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Vinblastine
Antineoplastic Agents
Molecules
Catharanthus
Civilization
Neoplasms
Chemotherapy
Medical problems
Bioactivity
Alkaloids
Functional groups
History
Clinical Trials
Databases
Drug Therapy
Health

Keywords

  • Alkaloids
  • Antineoplastic agents
  • Cancer
  • Clinical trials
  • Derivatives
  • Vinblastine

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Next generation antineoplastic agents : A review on structurally modified vinblastine (VBL) analogues. / Haque, Ashanul; Rahman, Md Ataur; Faizi, Md Serajul Haque; Khan, Muhammad.

In: Current Medicinal Chemistry, Vol. 25, No. 14, 01.01.2018, p. 1650-1662.

Research output: Contribution to journalReview article

Haque, Ashanul ; Rahman, Md Ataur ; Faizi, Md Serajul Haque ; Khan, Muhammad. / Next generation antineoplastic agents : A review on structurally modified vinblastine (VBL) analogues. In: Current Medicinal Chemistry. 2018 ; Vol. 25, No. 14. pp. 1650-1662.
@article{9c975331bd3e449c9af3e44a4a488d8b,
title = "Next generation antineoplastic agents: A review on structurally modified vinblastine (VBL) analogues",
abstract = "Background: Throughout the history of human civilizations, cancer has been a major health problem. Despite the advancements made by modern medical sciences, complete treatment or removal of cancerous cells is still a challenging task. Vinblastine, an alkaloid obtained from Catharanthus roseus (L.) G. Don is one of the prominent antineoplastic agents that is being clinically used. To improve the biological potential and reduce sideeffects of this structurally complex molecule, several related analogues have been reported. The present article reviews recently reported structurally modified vinblastine analogues and its impact on biological activity. Methods: We carried out a comprehensive database search on recently reported vinblastine analogues. Both upper (catharanthine) and lower (vindoline) structural units have been considered. The role of functional group modification on anticancer activities has been discussed. In addition, formulations based on vinblastine being considered by NIH, USA for different types of cancers have also been discussed._ Results: Around fifty papers were included in the review, including computational and experimental ones. These papers were analysed to discuss the mechanism of action of the parent vinblastine molecule and their analogues. The importance of each functionalities on its anticancer activity have been discussed. This reviewed identified the potential sites of vinblastine core where modification led to improved anticancer activity. Furthermore, several new formulations have also been discussed which are under different phases of clinical trial. Conclusion: The present article highlights the importance of vinblastine in cancer chemotherapy. Literature survey confirms that it is now possible to synthesize new molecules with activity in picomolar range. Not only the periphery of the molecule, the core structure of this magical molecule can be modified to achieve next generation antineoplastic agents.",
keywords = "Alkaloids, Antineoplastic agents, Cancer, Clinical trials, Derivatives, Vinblastine",
author = "Ashanul Haque and Rahman, {Md Ataur} and Faizi, {Md Serajul Haque} and Muhammad Khan",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/0929867324666170502123639",
language = "English",
volume = "25",
pages = "1650--1662",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "14",

}

TY - JOUR

T1 - Next generation antineoplastic agents

T2 - A review on structurally modified vinblastine (VBL) analogues

AU - Haque, Ashanul

AU - Rahman, Md Ataur

AU - Faizi, Md Serajul Haque

AU - Khan, Muhammad

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Throughout the history of human civilizations, cancer has been a major health problem. Despite the advancements made by modern medical sciences, complete treatment or removal of cancerous cells is still a challenging task. Vinblastine, an alkaloid obtained from Catharanthus roseus (L.) G. Don is one of the prominent antineoplastic agents that is being clinically used. To improve the biological potential and reduce sideeffects of this structurally complex molecule, several related analogues have been reported. The present article reviews recently reported structurally modified vinblastine analogues and its impact on biological activity. Methods: We carried out a comprehensive database search on recently reported vinblastine analogues. Both upper (catharanthine) and lower (vindoline) structural units have been considered. The role of functional group modification on anticancer activities has been discussed. In addition, formulations based on vinblastine being considered by NIH, USA for different types of cancers have also been discussed._ Results: Around fifty papers were included in the review, including computational and experimental ones. These papers were analysed to discuss the mechanism of action of the parent vinblastine molecule and their analogues. The importance of each functionalities on its anticancer activity have been discussed. This reviewed identified the potential sites of vinblastine core where modification led to improved anticancer activity. Furthermore, several new formulations have also been discussed which are under different phases of clinical trial. Conclusion: The present article highlights the importance of vinblastine in cancer chemotherapy. Literature survey confirms that it is now possible to synthesize new molecules with activity in picomolar range. Not only the periphery of the molecule, the core structure of this magical molecule can be modified to achieve next generation antineoplastic agents.

AB - Background: Throughout the history of human civilizations, cancer has been a major health problem. Despite the advancements made by modern medical sciences, complete treatment or removal of cancerous cells is still a challenging task. Vinblastine, an alkaloid obtained from Catharanthus roseus (L.) G. Don is one of the prominent antineoplastic agents that is being clinically used. To improve the biological potential and reduce sideeffects of this structurally complex molecule, several related analogues have been reported. The present article reviews recently reported structurally modified vinblastine analogues and its impact on biological activity. Methods: We carried out a comprehensive database search on recently reported vinblastine analogues. Both upper (catharanthine) and lower (vindoline) structural units have been considered. The role of functional group modification on anticancer activities has been discussed. In addition, formulations based on vinblastine being considered by NIH, USA for different types of cancers have also been discussed._ Results: Around fifty papers were included in the review, including computational and experimental ones. These papers were analysed to discuss the mechanism of action of the parent vinblastine molecule and their analogues. The importance of each functionalities on its anticancer activity have been discussed. This reviewed identified the potential sites of vinblastine core where modification led to improved anticancer activity. Furthermore, several new formulations have also been discussed which are under different phases of clinical trial. Conclusion: The present article highlights the importance of vinblastine in cancer chemotherapy. Literature survey confirms that it is now possible to synthesize new molecules with activity in picomolar range. Not only the periphery of the molecule, the core structure of this magical molecule can be modified to achieve next generation antineoplastic agents.

KW - Alkaloids

KW - Antineoplastic agents

KW - Cancer

KW - Clinical trials

KW - Derivatives

KW - Vinblastine

UR - http://www.scopus.com/inward/record.url?scp=85048860396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048860396&partnerID=8YFLogxK

U2 - 10.2174/0929867324666170502123639

DO - 10.2174/0929867324666170502123639

M3 - Review article

VL - 25

SP - 1650

EP - 1662

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 14

ER -